Stephanie Dorman

MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

Debashis Sarker, Ruth Plummer, Tim Meyer et al. · Clinical Cancer Research · 2020 · 156 citations · Full text

Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning

Stephanie Dorman, Katherina Baranova, Joan H.M. Knoll et al. · Molecular Oncology · 2015 · 122 citations · Full text

Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer

Vikash Reebye, Kai‐Wen Huang, Vivian Lin et al. · Oncogene · 2018 · 92 citations · Full text

Tumor Biology, Gene Activation, Preclinical Studies +21

Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile

Kai‐Wen Huang, Vikash Reebye, Katherine Czysz et al. · Molecular Therapy — Nucleic Acids · 2019 · 86 citations · Full text

Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer

Stephanie Dorman, Coby Viner, Peter K. Rogan · Scientific Reports · 2014 · 36 citations · Full text